Connor, Clark & Lunn Investment Management (CC&L)’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-28,153
Closed -$191K 1688
2025
Q4
$191K Sell
28,153
-151,271
-84% -$1.06M ﹤0.01% 1454
2025
Q3
$1.25M Buy
179,424
+35,258
+24% +$245K ﹤0.01% 996
2025
Q2
$881K Buy
144,166
+8,272
+6% +$55K ﹤0.01% 1087
2025
Q1
$1.03M Buy
135,894
+27,899
+26% +$233K ﹤0.01% 937
2024
Q4
$1.04M Sell
107,995
-164,405
-60% -$1.28M ﹤0.01% 918
2024
Q3
$1.61M Sell
272,400
-33,659
-11% -$223K 0.01% 721
2024
Q2
$2.12M Sell
306,059
-4,793
-2% -$33.7K 0.01% 639
2024
Q1
$2.39M Sell
310,852
-84,532
-21% -$679K 0.01% 622
2023
Q4
$3.47M Sell
395,384
-26,287
-6% -$192K 0.02% 526
2023
Q3
$3.07M Sell
421,671
-10,528
-2% -$78.4K 0.02% 510
2023
Q2
$2.86M Buy
432,199
+393,655
+1,021% +$2.01M 0.01% 513
2023
Q1
$131K Buy
+38,544
New +$149K ﹤0.01% 1133
2021
Q4
Sell
-32,384
Closed -$196K 1150
2021
Q3
$196K Buy
+32,384
New +$365K ﹤0.01% 949

Other funds holding MDXG

Connor, Clark & Lunn Investment Management (CC&L)'s MDXG Position: Q1 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of MiMedx Group (MDXG) in Q1 2026, closing a stake of 28,153 shares — an estimated $191K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in MDXG in Q3 2021 and held it in 13 quarters. The position peaked at $3.47M in Q4 2023. 238 funds tracked by Wall St. Rank hold MDXG as of Q1 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining MiMedx Group position as of Q1 2026 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 28,153 MiMedx Group shares in Q1 2026, an estimated $191K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in MiMedx Group in Q3 2021 and held it in 13 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s MiMedx Group position peaked at $3.47M in Q4 2023.
  • 238 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2026, filed 11 May 2026.